In this issue:
NCCN — Prostate Cancer guideline iterations, January 23, 2026
ESMO clinical practice guideline – Advanced and metastatic prostate cancer
ASCO Living Clinical Practice guideline – Ongoing 2026 update process
PBS co-payment reduction
FDA clears phase 2b prostate cancer study of Teverelix
FDA continues oncology regulatory actions
AU/NZ prostate cancer clinical trials in recruitment
Salvage focal therapy shows promise after radiotherapy recurrence
Hot flashes in hormone therapy may be reduced with oxybutynin
ASCO GU 2026 — Planning dates through February 2026
Conferences, Workshops, CPD
Research Review Publications
Please login below to download this issue (PDF)